WP001/ECP039/0113: Exploring the feasibility of a new regulatory paradigm for the manufacture of autologous cell therapies (2013)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Regenerative Medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Working Paper